© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Success as a CEO  in Drug Development
Posted 26th June 2017

Success as a CEO in Drug Development

Under the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Success as a CEO in Drug Development
Image

Under the Business Elite Awards 2017, the exclusive CEO of the Year – Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Francesco Sinigaglia is the CEO and co-founder of Anabasis, an Italian biopharmaceutical company developing Nerve Growth Factor (NGF) for severe eye diseases. In 2011, he sold Anabasis to Dompé for approximately 10 million upfront and 160 million in regulatory and commercial milestones. Francesco’s industry expertise lies in the life science, biotechnology and pharmaceutical sectors.

He starts the interview by detailing his role following the acquisition and his undoubted experience as a seasoned professional in the industry, plus his reflections on his greatest professional achievement to date.

“After the acquisition, I remained on board as COO to complete the development of the NGF. It was a great success, indeed NGF is now being approved in the EU by European Medicines Agency (EMA).

“Going back a bit, I spent more than 35 years in the biotech and pharmaceutical industry. This included 20 years at Roche, with the first 10 of these at the company’s headquarters in Basel and then as a research director in Italy. In 2002, I founded my first biotech company, Bioxell, that I took public on the Swiss Stock Exchange in 2006 and sold it to Cosmo Pharmaceutical three years later. In 2009, I founded the company Anabasis.

“My biggest achievement is the success of Anabasis, both in terms of scientific and clinical development and for the ability to create value. We financed the development programmes by ourselves and through the collaboration agreement with Dompé, thus avoiding the financial support of venture capital and consequently value dilution.”

Francesco then offers his thoughts on what makes him stand out from other CEO’s and the advice he would you give to anyone wishing to pursue the same career route.

“Drug development is a difficult and risky business. Indeed, only a very few drugs are approved each year and these are mostly from large multinational organisations. To have been able, with rather limited resources, to complete the preclinical, clinical and regulatory development and obtain approval by the regulatory authorities is indeed for me a very major achievement.

“For anybody wishing to take the same career route as me, I would underline that, if you believe that you have a good business idea, just go for it don’t be afraid to fail. It is very true to say that failure is a very important component of the learning process.”

Finally, Francesco draws our attention to another accolade he has won over the past 12 months, including the Best Biopharmaceutical Company – Italy and Excellence Award for Industrial Research 2017, as well as the Business Elite Awards 2017 CEO of the Year – Italy award that this feature interview celebrates.

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Challenges Facing Transportation Companies in an Increasingly Digital World
Strategy
03/08/2026Challenges Facing Transportation Companies in an Increasingly Digital World

The transportation industry is one of the most dynamic times in its history. Digital technologies have changed the way goods are transported, fleets are managed, and customers are connected with providers. These developments provide significant opportunities t

Read Full PostRead - Eye Icon
How to do Estate Planning Properly
News
29/08/2023How to do Estate Planning Properly

Estate planning is the process of designating who will receive your assets in the event of your death or incapacitation. Having a well-thought-out estate plan is the most reliable way to ensure that heirs and beneficiaries correctly receive the assets. More of

Read Full PostRead - Eye Icon
Cost-Effective Ways to Upgrade School Facilities
News
27/09/2024Cost-Effective Ways to Upgrade School Facilities

With an increased demand for efficiency and modernity in educational institutions, School Administrators often face tight budgets when upgrading school facilities, but some cost-effective renovations can bring significant improvements. Implementing thoughtful,

Read Full PostRead - Eye Icon
Deal of the Year: Dubai Investments Completes Acquisition in Al Mal Capital
Finance
01/03/2016Deal of the Year: Dubai Investments Completes Acquisition in Al Mal Capital

Dubai Investments PJSC is a leading investment company listed on the Dubai Financial Market with over 19,800 shareholders and a paid-up capital of AED 4 billion.

Read Full PostRead - Eye Icon
Is it Possible to Increase the Recognition of Your Business Using 3D Modeling?
Innovation
14/08/2024Is it Possible to Increase the Recognition of Your Business Using 3D Modeling?

In today’s highly competitive business landscape, standing out and being recognizable are paramount for success. Companies are constantly searching for innovative ways to capture their audience’s attention and distinguish themselves from competitor

Read Full PostRead - Eye Icon
LANDESK Finalizes AppSense Acquisition, Advances Lead in Unified Endpoint Management with Extended U
M&A
19/04/2016LANDESK Finalizes AppSense Acquisition, Advances Lead in Unified Endpoint Management with Extended U

LANDESK today announced it has completed the acquisition of California-based AppSense, the leading provider of secure user environment management solutions.

Read Full PostRead - Eye Icon
Navigating the Legal Landscape of Noncompete Agreements in M&A
Legal
20/05/2025Navigating the Legal Landscape of Noncompete Agreements in M&A

While not every buyout or merger includes noncompetes, understanding how to approach these clauses can be critical to successful deal-making.

Read Full PostRead - Eye Icon
Running a Professional Options Trading Business from Home
Innovation
21/02/2023Running a Professional Options Trading Business from Home

When you run a professional options trading business, you gain the right to buy or sell assets at a set price prior to a specific date. These days, investors can begin options trading from home. Do it right, and you could end up with healthy profits.

Read Full PostRead - Eye Icon
Why Nonprofits Need Grant Management Software Solutions
Strategy
27/10/2025Why Nonprofits Need Grant Management Software Solutions

You need reliable grant management software solutions for nonprofits to stay ahead in a competitive funding environment. With more organizations chasing fewer grants, every missed deadline or misplaced document can cost you valuable opportunities. Managing mul



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow